Global Pharmaceutical Regulatory Affairs Market Growth (Status and Outlook) 2022-2028
- Category: Medical
- Published Date: Mar 2022
- Publisher: LP Information
- Pages: 123
As the global economy mends, the 2021 growth of Pharmaceutical Regulatory Affairs will have significant change from previous year. According to our (Intelligence Market Report) latest study, the global Pharmaceutical Regulatory Affairs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pharmaceutical Regulatory Affairs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Pharmaceutical Regulatory Affairs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Regulatory Affairs market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Regulatory Affairs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmaceutical Regulatory Affairs players cover QuintilesIMS, LabCor, PAREXEL, and Pharmaceutical Product Development, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Regulatory Affairs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
In-house
Outsourcing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
The United States Pharmaceutical Regulatory Affairs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Regulatory Affairs market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Regulatory Affairs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmaceutical Regulatory Affairs players cover QuintilesIMS, LabCor, PAREXEL, and Pharmaceutical Product Development, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Regulatory Affairs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
In-house
Outsourcing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Regulatory Affairs Market Size 2017-2028
2.1.2 Pharmaceutical Regulatory Affairs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Regulatory Affairs Segment by Type
2.2.1 Regulatory Consulting
2.2.2 Legal Representation
2.2.3 Regulatory Writing & Publishing
2.2.4 Product Registration & Clinical Trial Application
2.2.5 Other Services
2.3 Pharmaceutical Regulatory Affairs Market Size by Type
2.3.1 Pharmaceutical Regulatory Affairs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Regulatory Affairs Segment by Application
2.4.1 In-house
2.4.2 Outsourcing
2.5 Pharmaceutical Regulatory Affairs Market Size by Application
2.5.1 Pharmaceutical Regulatory Affairs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2017-2022)
3 Pharmaceutical Regulatory Affairs Market Size by Player
3.1 Pharmaceutical Regulatory Affairs Market Size Market Share by Players
3.1.1 Global Pharmaceutical Regulatory Affairs Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Regulatory Affairs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Regulatory Affairs by Regions
4.1 Pharmaceutical Regulatory Affairs Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pharmaceutical Regulatory Affairs Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Regulatory Affairs Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs by Country (2017-2022)
7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Regulatory Affairs by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Regulatory Affairs Market Forecast
10.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Regulatory Affairs Forecast
10.1.3 APAC Pharmaceutical Regulatory Affairs Forecast
10.1.4 Europe Pharmaceutical Regulatory Affairs Forecast
10.1.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast
10.2 Americas Pharmaceutical Regulatory Affairs Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Regulatory Affairs Market Forecast
10.2.2 Canada Pharmaceutical Regulatory Affairs Market Forecast
10.2.3 Mexico Pharmaceutical Regulatory Affairs Market Forecast
10.2.4 Brazil Pharmaceutical Regulatory Affairs Market Forecast
10.3 APAC Pharmaceutical Regulatory Affairs Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Regulatory Affairs Market Forecast
10.3.2 Japan Pharmaceutical Regulatory Affairs Market Forecast
10.3.3 Korea Pharmaceutical Regulatory Affairs Market Forecast
10.3.4 Southeast Asia Pharmaceutical Regulatory Affairs Market Forecast
10.3.5 India Pharmaceutical Regulatory Affairs Market Forecast
10.3.6 Australia Pharmaceutical Regulatory Affairs Market Forecast
10.4 Europe Pharmaceutical Regulatory Affairs Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Regulatory Affairs Market Forecast
10.4.2 France Pharmaceutical Regulatory Affairs Market Forecast
10.4.3 UK Pharmaceutical Regulatory Affairs Market Forecast
10.4.4 Italy Pharmaceutical Regulatory Affairs Market Forecast
10.4.5 Russia Pharmaceutical Regulatory Affairs Market Forecast
10.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Regulatory Affairs Market Forecast
10.5.2 South Africa Pharmaceutical Regulatory Affairs Market Forecast
10.5.3 Israel Pharmaceutical Regulatory Affairs Market Forecast
10.5.4 Turkey Pharmaceutical Regulatory Affairs Market Forecast
10.5.5 GCC Countries Pharmaceutical Regulatory Affairs Market Forecast
10.6 Global Pharmaceutical Regulatory Affairs Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Regulatory Affairs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Information
11.1.2 QuintilesIMS Pharmaceutical Regulatory Affairs Product Offered
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 QuintilesIMS Main Business Overview
11.1.5 QuintilesIMS Latest Developments
11.2 LabCor
11.2.1 LabCor Company Information
11.2.2 LabCor Pharmaceutical Regulatory Affairs Product Offered
11.2.3 LabCor Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 LabCor Main Business Overview
11.2.5 LabCor Latest Developments
11.3 PAREXEL
11.3.1 PAREXEL Company Information
11.3.2 PAREXEL Pharmaceutical Regulatory Affairs Product Offered
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 PAREXEL Main Business Overview
11.3.5 PAREXEL Latest Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Information
11.4.2 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product Offered
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pharmaceutical Product Development Main Business Overview
11.4.5 Pharmaceutical Product Development Latest Developments
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Information
11.5.2 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product Offered
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 INC RESEARCH HOLDINGS Main Business Overview
11.5.5 INC RESEARCH HOLDINGS Latest Developments
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Information
11.6.2 PRA Health Sciences Pharmaceutical Regulatory Affairs Product Offered
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 PRA Health Sciences Main Business Overview
11.6.5 PRA Health Sciences Latest Developments
11.7 ICON
11.7.1 ICON Company Information
11.7.2 ICON Pharmaceutical Regulatory Affairs Product Offered
11.7.3 ICON Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ICON Main Business Overview
11.7.5 ICON Latest Developments
11.8 Charles River
11.8.1 Charles River Company Information
11.8.2 Charles River Pharmaceutical Regulatory Affairs Product Offered
11.8.3 Charles River Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Charles River Main Business Overview
11.8.5 Charles River Latest Developments
11.9 Advent International
11.9.1 Advent International Company Information
11.9.2 Advent International Pharmaceutical Regulatory Affairs Product Offered
11.9.3 Advent International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Advent International Main Business Overview
11.9.5 Advent International Latest Developments
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Information
11.10.2 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 WuXi AppTec, Inc. Main Business Overview
11.10.5 WuXi AppTec, Inc. Latest Developments
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Information
11.11.2 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Pharmaron Beijing Co., Ltd. Main Business Overview
11.11.5 Pharmaron Beijing Co., Ltd. Latest Developments
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Information
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Main Business Overview
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Latest Developments
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Information
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Main Business Overview
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Latest Developments
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Information
11.14.2 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product Offered
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Accell Clinical Research, LLC. Main Business Overview
11.14.5 Accell Clinical Research, LLC. Latest Developments
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Information
11.15.2 GenPact Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 GenPact Ltd. Main Business Overview
11.15.5 GenPact Ltd. Latest Developments
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Information
11.16.2 Criterium, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Criterium, Inc. Main Business Overview
11.16.5 Criterium, Inc. Latest Developments
11.17 Promedica International
11.17.1 Promedica International Company Information
11.17.2 Promedica International Pharmaceutical Regulatory Affairs Product Offered
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Promedica International Main Business Overview
11.17.5 Promedica International Latest Developments
11.18 Medpace
11.18.1 Medpace Company Information
11.18.2 Medpace Pharmaceutical Regulatory Affairs Product Offered
11.18.3 Medpace Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Medpace Main Business Overview
11.18.5 Medpace Latest Developments
11.19 Covance
11.19.1 Covance Company Information
11.19.2 Covance Pharmaceutical Regulatory Affairs Product Offered
11.19.3 Covance Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Covance Main Business Overview
11.19.5 Covance Latest Developments
11.20 Freyr
11.20.1 Freyr Company Information
11.20.2 Freyr Pharmaceutical Regulatory Affairs Product Offered
11.20.3 Freyr Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Freyr Main Business Overview
11.20.5 Freyr Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Regulatory Affairs Market Size 2017-2028
2.1.2 Pharmaceutical Regulatory Affairs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Regulatory Affairs Segment by Type
2.2.1 Regulatory Consulting
2.2.2 Legal Representation
2.2.3 Regulatory Writing & Publishing
2.2.4 Product Registration & Clinical Trial Application
2.2.5 Other Services
2.3 Pharmaceutical Regulatory Affairs Market Size by Type
2.3.1 Pharmaceutical Regulatory Affairs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Regulatory Affairs Segment by Application
2.4.1 In-house
2.4.2 Outsourcing
2.5 Pharmaceutical Regulatory Affairs Market Size by Application
2.5.1 Pharmaceutical Regulatory Affairs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2017-2022)
3 Pharmaceutical Regulatory Affairs Market Size by Player
3.1 Pharmaceutical Regulatory Affairs Market Size Market Share by Players
3.1.1 Global Pharmaceutical Regulatory Affairs Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Regulatory Affairs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Regulatory Affairs by Regions
4.1 Pharmaceutical Regulatory Affairs Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pharmaceutical Regulatory Affairs Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Regulatory Affairs Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs by Country (2017-2022)
7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Regulatory Affairs by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Regulatory Affairs Market Forecast
10.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Regulatory Affairs Forecast
10.1.3 APAC Pharmaceutical Regulatory Affairs Forecast
10.1.4 Europe Pharmaceutical Regulatory Affairs Forecast
10.1.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast
10.2 Americas Pharmaceutical Regulatory Affairs Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Regulatory Affairs Market Forecast
10.2.2 Canada Pharmaceutical Regulatory Affairs Market Forecast
10.2.3 Mexico Pharmaceutical Regulatory Affairs Market Forecast
10.2.4 Brazil Pharmaceutical Regulatory Affairs Market Forecast
10.3 APAC Pharmaceutical Regulatory Affairs Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Regulatory Affairs Market Forecast
10.3.2 Japan Pharmaceutical Regulatory Affairs Market Forecast
10.3.3 Korea Pharmaceutical Regulatory Affairs Market Forecast
10.3.4 Southeast Asia Pharmaceutical Regulatory Affairs Market Forecast
10.3.5 India Pharmaceutical Regulatory Affairs Market Forecast
10.3.6 Australia Pharmaceutical Regulatory Affairs Market Forecast
10.4 Europe Pharmaceutical Regulatory Affairs Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Regulatory Affairs Market Forecast
10.4.2 France Pharmaceutical Regulatory Affairs Market Forecast
10.4.3 UK Pharmaceutical Regulatory Affairs Market Forecast
10.4.4 Italy Pharmaceutical Regulatory Affairs Market Forecast
10.4.5 Russia Pharmaceutical Regulatory Affairs Market Forecast
10.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Regulatory Affairs Market Forecast
10.5.2 South Africa Pharmaceutical Regulatory Affairs Market Forecast
10.5.3 Israel Pharmaceutical Regulatory Affairs Market Forecast
10.5.4 Turkey Pharmaceutical Regulatory Affairs Market Forecast
10.5.5 GCC Countries Pharmaceutical Regulatory Affairs Market Forecast
10.6 Global Pharmaceutical Regulatory Affairs Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Regulatory Affairs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Information
11.1.2 QuintilesIMS Pharmaceutical Regulatory Affairs Product Offered
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 QuintilesIMS Main Business Overview
11.1.5 QuintilesIMS Latest Developments
11.2 LabCor
11.2.1 LabCor Company Information
11.2.2 LabCor Pharmaceutical Regulatory Affairs Product Offered
11.2.3 LabCor Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 LabCor Main Business Overview
11.2.5 LabCor Latest Developments
11.3 PAREXEL
11.3.1 PAREXEL Company Information
11.3.2 PAREXEL Pharmaceutical Regulatory Affairs Product Offered
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 PAREXEL Main Business Overview
11.3.5 PAREXEL Latest Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Information
11.4.2 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product Offered
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pharmaceutical Product Development Main Business Overview
11.4.5 Pharmaceutical Product Development Latest Developments
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Information
11.5.2 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product Offered
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 INC RESEARCH HOLDINGS Main Business Overview
11.5.5 INC RESEARCH HOLDINGS Latest Developments
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Information
11.6.2 PRA Health Sciences Pharmaceutical Regulatory Affairs Product Offered
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 PRA Health Sciences Main Business Overview
11.6.5 PRA Health Sciences Latest Developments
11.7 ICON
11.7.1 ICON Company Information
11.7.2 ICON Pharmaceutical Regulatory Affairs Product Offered
11.7.3 ICON Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ICON Main Business Overview
11.7.5 ICON Latest Developments
11.8 Charles River
11.8.1 Charles River Company Information
11.8.2 Charles River Pharmaceutical Regulatory Affairs Product Offered
11.8.3 Charles River Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Charles River Main Business Overview
11.8.5 Charles River Latest Developments
11.9 Advent International
11.9.1 Advent International Company Information
11.9.2 Advent International Pharmaceutical Regulatory Affairs Product Offered
11.9.3 Advent International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Advent International Main Business Overview
11.9.5 Advent International Latest Developments
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Information
11.10.2 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 WuXi AppTec, Inc. Main Business Overview
11.10.5 WuXi AppTec, Inc. Latest Developments
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Information
11.11.2 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Pharmaron Beijing Co., Ltd. Main Business Overview
11.11.5 Pharmaron Beijing Co., Ltd. Latest Developments
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Information
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Main Business Overview
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Latest Developments
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Information
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Main Business Overview
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Latest Developments
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Information
11.14.2 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product Offered
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Accell Clinical Research, LLC. Main Business Overview
11.14.5 Accell Clinical Research, LLC. Latest Developments
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Information
11.15.2 GenPact Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 GenPact Ltd. Main Business Overview
11.15.5 GenPact Ltd. Latest Developments
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Information
11.16.2 Criterium, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Criterium, Inc. Main Business Overview
11.16.5 Criterium, Inc. Latest Developments
11.17 Promedica International
11.17.1 Promedica International Company Information
11.17.2 Promedica International Pharmaceutical Regulatory Affairs Product Offered
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Promedica International Main Business Overview
11.17.5 Promedica International Latest Developments
11.18 Medpace
11.18.1 Medpace Company Information
11.18.2 Medpace Pharmaceutical Regulatory Affairs Product Offered
11.18.3 Medpace Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Medpace Main Business Overview
11.18.5 Medpace Latest Developments
11.19 Covance
11.19.1 Covance Company Information
11.19.2 Covance Pharmaceutical Regulatory Affairs Product Offered
11.19.3 Covance Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Covance Main Business Overview
11.19.5 Covance Latest Developments
11.20 Freyr
11.20.1 Freyr Company Information
11.20.2 Freyr Pharmaceutical Regulatory Affairs Product Offered
11.20.3 Freyr Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Freyr Main Business Overview
11.20.5 Freyr Latest Developments
12 Research Findings and Conclusion
no record found